Sale

Healthcare Contract Manufacturing Market

Global Healthcare Contract Manufacturing Market Size, Share, Forecast: By Service: Medical Device, Pharmaceutical; By Type: Sterile, Non-Sterile; By Class: Class I, Class II, Class III; By Type of Manufacturing: Raw Material, Electronics, Finished Goods; By End User: Medical Device Companies, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Healthcare Contract Manufacturing Market Outlook

The global healthcare contract manufacturing market size was valued at USD 261.01 billion in 2023, driven by the increasing technical advancements in diagnostic tools across the globe. The market size is anticipated to grow at a CAGR of 9.4% during the forecast period of 2024-2032 to achieve a value of USD 587.83 billion by 2032.

 

Healthcare Contract Manufacturing: Introduction

Medical device contract manufacturing is a process where a MedTech company uses the help of drug manufacturing companies to formulate and develop their patented and authorized drugs and take care of the further process in the market. A company working for another company on their behalf due to the absence of hardware and area to perform the whole research, formulation and development and manufacturing of drugs on a contract-based relationship, is known as healthcare contract manufacturing.

 

There are several benefits that a MedTech company avails while in contract with the manufacturing company, such as cost-optimized manufacturing of drugs, the availability of experience and technology across various segments that can be utilized to upscale the project. The contract also provides with effective regulatory compliant manufacturing, increased access across various parts of the globe to maximize the networking and reach of the products.

 

Pharmaceutical contract manufacturing is the process in which pharmaceutical drugs are manufactured on a contract basis. There are several types of drugs and ways they are administered, but the most common drug delivery systems are oral, topical, and parenteral (injection).

 

Global Healthcare Contract Manufacturing Market Analysis

The increased outsourcing by pharmaceutical companies and other medical companies to cut on their production expenditures and add on to the efforts and expenses on marketing of those drugs is a major key trend in the market driving the healthcare contract manufacturing market growth. The demand for more advanced formulated and personalized drug treatments are also increasing the demand.

 

Additionally, the increasing number of medical patients and noninvasive surgical procedures are directly increasing the demand for pharmaceutical drugs globally. To curb this increased demand, pharmaceutical companies are taking help of healthcare contract manufacturing companies.

 

Global Healthcare Contract Manufacturing Market Segmentations

Market Breakup by Service

  • Medical Device 
    • Service 
    • Accessories Manufacturing 
    • Assembly Manufacturing 
    • Component Manufacturing 
    • Device Manufacturing 
    • Therapeutic Area 
    • Cardiology 
    • Diagnostic Imaging 
    • Orthopaedic 
    • IVD 
    • Ophthalmic 
    • General and Plastic Surgery 
    • Drug Delivery 
    • Dental 
    • Endoscopy 
    • Diabetes Care 
    • Others
  • Pharmaceutical 
    • Service 
    • API/Bulk Drugs 
    • Advanced Drug Delivery Formulation 
    • Packaging 
    • Finished Dose Formulations 
      • Solid 
      • Liquid 
      • Semisolid

 

Market Breakup by Type

  • Sterile
  • Non-Sterile

 

Market Breakup by Class

  • Class I
  • Class II
  • Class III

 

Market Breakup by Type of Manufacturing

  • Raw Material
  • Electronics 
  • Finished Goods

 

Market Breakup by End User

  • Medical Device Companies
  • Pharmaceutical Companies
  • Biopharmaceutical Companies

 

Market Breakup by Region

  • North America 
  • Europe
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global Healthcare Contract Manufacturing Market Overview

The pharmaceutical manufacturing process is evolving. The development of drugs involves years of research and testing to come up to a decision where it is confirmed that the research is through and now the manufacturing and applications may be put to use in the market. Increasing advancements in manufacturing technologies, such as continuous manufacturing, single-use technologies, and 3D printing, among others, can also potentially drive the market. The increased pressure to reduce costs and improve operational efficiency is also a significant driver for healthcare contract manufacturing market expansion.

 

Additionally, manufacturing safe and stable drugs is an expensive task. Hence, partnering with an industry leading CMO/CDMO gives companies new opportunities in complicated drug manufacturing market. The increasing patient population worldwide is a major driver driving the healthcare contract manufacturing market expansion as the demand for drugs manufacturing and administration is increased. Due to the low risk of product carryover and resulting market expansion, the utilization of multi product facilities to create biologics has been shown to be both economically effective and secure aiding the expansion of healthcare contract manufacturing market development.

 

Global Healthcare Contract Manufacturing Market Share by Region

Geographically, the North America is leading the global market due to the presence of multiple key players in the region. The growth of the market can be attributed to the developed and rapidly advancing healthcare sector in the region, along with the rising presence of the key players in the region.

 

Global Healthcare Contract Manufacturing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Thermo Fisher Scientific 
  • Lonza 
  • Celestica Inc. 
  • Integer Holdings Corporation 
  • Nordson Corporation 
  • Sanmina Corporation 
  • Phillips-Medisize - a Molex Company 
  • Catalent, Inc 
  • Boehringer Ingelheim International GmbH 
  • Samsung Biologics 
  • WuXi AppTec 
  • Cambrex Corporation 
  • Recifarm

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Service
  • Type
  • Class
  • Type of Manufacturing
  • End User
  • Region
Breakup by Service
  • Medical Device
  • Pharmaceutical
Breakup by Type
  • Sterile
  • Non-Sterile

Breakup by Class

  • Class I
  • Class II
  • Class III
Breakup by Type of Manufacturing
  • Raw Material
  • Electronics 
  • Finished Goods
Breakup by End User
  • Medical Device Companies
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Thermo Fisher Scientific 
  • Lonza 
  • Celestica Inc. 
  • Integer Holdings Corporation 
  • Nordson Corporation 
  • Sanmina Corporation 
  • Phillips-Medisize - a Molex Company 
  • Catalent, Inc 
  • Boehringer Ingelheim International GmbH 
  • Samsung Biologics 
  • WuXi AppTec 
  • Cambrex Corporation 
  • Recifarm

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Healthcare Contract Manufacturing Market Overview
 
    3.1    Global Healthcare Contract Manufacturing Market Historical Value (2017-2023) 
    3.2    Global Healthcare Contract Manufacturing Market Forecast Value (2024-2032)
4    Global Healthcare Contract Manufacturing Market Landscape
    4.1    Global Healthcare Contract Manufacturing Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Healthcare Contract Manufacturing Product Landscape
        4.2.1    Analysis by Service
        4.2.2    Analysis by Type
        4.2.3    Analysis by Class
        4.2.4    Analysis by Type of Manufacturing
5    Global Healthcare Contract Manufacturing Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Healthcare Contract Manufacturing Market Segmentation 
    6.1    Global Healthcare Contract Manufacturing Market by Service
        6.1.1    Market Overview 
        6.1.2    Medical Device
            6.1.2.1    Service
                6.1.2.1.1    Accessories Manufacturing
                6.1.2.1.2    Assembly Manufacturing
                6.1.2.1.3    Component Manufacturing
                6.1.2.1.4    Device Manufacturing
            6.1.2.2    Therapeutic Area
                6.1.2.2.1    Cardiology
                6.1.2.2.2    Diagnostic Imaging
                6.1.2.2.3    Orthopaedic
                6.1.2.2.4    IVD
                6.1.2.2.5    Ophthalmic
                6.1.2.2.6    General and Plastic Surgery
                6.1.2.2.7    Drug Delivery
                6.1.2.2.8    Dental
                6.1.2.2.9    Endoscopy
                6.1.2.2.10    Diabetes Care
                6.1.2.2.11    Others
        6.1.3    Pharmaceutical
            6.1.3.1    Service
                6.1.3.1.1    API/Bulk Drugs
                6.1.3.1.2    Advanced Drug Delivery Formulation
                6.1.3.1.3    Packaging
                6.1.3.1.4    Finished Dose Formulations
                    6.1.3.1.4.1    Solid
                    6.1.3.1.4.2    Liquid
                    6.1.3.1.4.3    Semisolid
    6.2    Global Healthcare Contract Manufacturing Market by Type
        6.2.1    Market Overview
        6.2.2    Sterile
        6.2.3    Non-Sterile
    6.3    Global Healthcare Contract Manufacturing Market by Class
        6.3.1    Market Overview
        6.3.2    Class I
        6.3.3    Class II
        6.3.4    Class III
    6.4    Global Healthcare Contract Manufacturing Market by Type of Manufacturing
        6.4.1    Market Overview
        6.4.2    Raw Material
        6.4.3    Electronics
        6.4.4    Finished Goods
    6.5    Global Healthcare Contract Manufacturing Market by End User
        6.5.1    Market Overview
        6.5.2    Medical Device Companies
        6.5.3    Pharmaceutical Companies
        6.5.4    Biopharmaceutical Companies
    6.6    Global Healthcare Contract Manufacturing Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Healthcare Contract Manufacturing Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Healthcare Contract Manufacturing Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Healthcare Contract Manufacturing Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Healthcare Contract Manufacturing Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Healthcare Contract Manufacturing Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Thermo Fisher Scientific
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Lonza
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Celestica Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Integer Holdings Corporation
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Nordson Corporation
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Sanmina Corporation
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Phillips-Medisize - a Molex Company
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Catalent, Inc
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Boehringer Ingelheim International GmbH
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Samsung Biologics
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    WuXi AppTec
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Cambrex Corporation
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Recifarm
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
18    Global Healthcare Contract Manufacturing Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 261.01 billion in 2023, driven by the rising prevalence of eye disorders.

The global market is anticipated to grow at a CAGR of 9.4% during the forecast period of 2024-2032 and reach a market value of USD 587.83 billion by 2032.

Increasing advancements in manufacturing technologies, such as continuous manufacturing and single-use technologies, among others are some of the key factors aiding the growth of the market.

The increase in outsourcing by pharmaceutical companies and other medical companies to cut on their production costs and invest it on the marketing of that drug is a major trend aiding the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa, with North America leading the global market.

The different types of services in the market include medical devices and pharmaceuticals, which are further broken into sub-categories.

The types in the market can be categorised into sterile and non-sterile.

The different classes in the market are class I, class II, and class III.

The types of manufacturing in the market are raw material, electronics, and finished goods.

The end users in the market are medical device companies, pharmaceutical companies, and biopharmaceutical companies.

Key players involved in the market are Thermo Fisher Scientific, Lonza, Celestica Inc., Integer Holdings Corporation, Nordson Corporation, Sanmina Corporation, Phillips-Medisize - a Molex Company, Catalent, Inc, Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Cambrex Corporation, and Recifarm.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER